Last reviewed · How we verify

PROCHLORPERAZINE MALEATE

FDA-approved approved Small molecule Quality 15/100

PROCHLORPERAZINE MALEATE is a drug. It is currently FDA-approved (first approved 1956) for Severe Nausea and Vomiting Control, Schizophrenia Treatment, Generalized Non-Psychotic Anxiety.

Prochlorperazine Maleate is a marketed drug primarily indicated for the control of severe nausea and vomiting. Its key strength lies in its established market presence, supported by a key composition patent expiring in 2028. The primary risk is the potential increase in competition as the patent expiration approaches.

At a glance

Generic namePROCHLORPERAZINE MALEATE
ModalitySmall molecule
PhaseFDA-approved
First approval1956

Approved indications

Common side effects

Serious adverse events

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
FDA labelMechanism, indications, dosing, boxed warnings, drug interactions
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about PROCHLORPERAZINE MALEATE

What is PROCHLORPERAZINE MALEATE?

PROCHLORPERAZINE MALEATE is a Small molecule drug, indicated for Severe Nausea and Vomiting Control, Schizophrenia Treatment, Generalized Non-Psychotic Anxiety.

What is PROCHLORPERAZINE MALEATE used for?

PROCHLORPERAZINE MALEATE is indicated for Severe Nausea and Vomiting Control, Schizophrenia Treatment, Generalized Non-Psychotic Anxiety.

When was PROCHLORPERAZINE MALEATE approved?

PROCHLORPERAZINE MALEATE was first approved on 1956.

What development phase is PROCHLORPERAZINE MALEATE in?

PROCHLORPERAZINE MALEATE is FDA-approved (marketed).

What are the side effects of PROCHLORPERAZINE MALEATE?

Common side effects of PROCHLORPERAZINE MALEATE include Drowsiness, Dizziness, Blurred vision, Skin reactions, Amenorrhea, Hypotension. Serious adverse events: Neuroleptic Malignant Syndrome (NMS), Cholestatic jaundice, Fatty changes in liver, Leukopenia.

Related